Literature DB >> 6681564

Lipomembranous polycystic osteodysplasia (brain, bone, and fat disease): a genetic cause of presenile dementia.

T D Bird, R M Koerker, B J Leaird, B W Vlcek, D R Thorning.   

Abstract

Progressive presenile dementia with lipomembranous polycystic osteodysplasia was first described by Jarvi and Hakola in an isolated region of Finland. We report the occurrence of this disorder in 4 of 10 siblings in an American family of Czechoslovakian ancestry. Characteristics of the disease include multiple bone cysts with pathologic fractures, progressive dementia with seizures and abnormal EEG, calcification of basal ganglia, and death in the fourth to six decades. Autosomal-recessive inheritance is likely. Electronmicroscopy of fat cells reveals peculiar membrane convolutions. Limited neuropathologic material has shown gliosis and demyelination of white matter, senile plaques, and neurofibrillary tangles. Leukemia and a disorder of intestinal motility may be associated findings. Prevalence of the disorder is unknown, partly because it may be confused with Alzheimer disease and fibrous dysplasia of bone. Radiographs of hands and feet should be part of the evaluation of patients with unexplained presenile dementia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6681564     DOI: 10.1212/wnl.33.1.81

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  Degenerative change of adipose tissue; the so-called membranous lipodystrophy.

Authors:  R Machinami
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 2.  Nasu-Hakola syndrome: polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy and presenile dementia.

Authors:  A Verloes; P Maquet; B Sadzot; M Vivario; A Thiry; G Franck
Journal:  J Med Genet       Date:  1997-09       Impact factor: 6.318

3.  Case report 867. Membranous lipodystrophy (polycystic lipomembranous osteodysplasia).

Authors:  N Koçer; S Dervisoglu; G Ersavasti; A Altug; O Cokyüksel
Journal:  Skeletal Radiol       Date:  1994-10       Impact factor: 2.199

4.  Assignment of the locus for PLO-SL, a frontal-lobe dementia with bone cysts, to 19q13.

Authors:  P Pekkarinen; I Hovatta; P Hakola; O Järvi; M Kestilä; U Lenkkeri; R Adolfsson; G Holmgren; P O Nylander; L Tranebjaerg; J D Terwilliger; J Lönnqvist; L Peltonen
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

5.  Ultrastructural demonstration of Maclura pomifera agglutinin binding sites in the membranocystic lesions of membranous lipodystrophy (Nasu-Hakola disease).

Authors:  I Kitajima; T Suganuma; F Murata; K Nagamatsu
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

Review 6.  The Triggering Receptor Expressed on Myeloid Cells 2: A Molecular Link of Neuroinflammation and Neurodegenerative Diseases.

Authors:  Jochen Walter
Journal:  J Biol Chem       Date:  2015-12-22       Impact factor: 5.157

7.  [Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy].

Authors:  B Lorch; K Henkel; H Schaab; W Aurnhammer; T Becker
Journal:  Nervenarzt       Date:  2006-01       Impact factor: 1.214

8.  Alzheimer's disease pathology in Nasu-Hakola disease brains.

Authors:  Jun-Ichi Satoh; Yoshihiro Kino; Motoaki Yanaizu; Yuko Saito
Journal:  Intractable Rare Dis Res       Date:  2018-02

9.  Ultrastructural lipid and glycoconjugate cytochemistry of membranous lipodystrophy (Nasu-Hakola disease).

Authors:  Y Mii; Y Miyauchi; T Yoshikawa; K Honoki; M Aoki; M Tsutsumi; H Maruyama; M Funauchi; Y Konishi; S Tamai
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

10.  Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype.

Authors:  Juha Paloneva; Tuula Manninen; Grant Christman; Karine Hovanes; Jami Mandelin; Rolf Adolfsson; Marino Bianchin; Thomas Bird; Roxana Miranda; Andrea Salmaggi; Lisbeth Tranebjaerg; Yrjö Konttinen; Leena Peltonen
Journal:  Am J Hum Genet       Date:  2002-06-21       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.